bullish
Bumrungrad Hospital Pub Co (BH TB): Flying High on Return of Medical Tourism
243 Views28 Aug 2022 18:27
SUMMARY
- Bumrungrad Hospital Pub Co (BH TB) reported strong Q2 2022 results, with revenue growth of 64% y/y, mainy driven by a 121% y/y increase in revenue from non-Thai patients.
- Despite international patient volume is recovering, it is still lower than pre-COVID levels. Non-Thai patients contributed 66.2% of total revenue in Q2 2019, higher than 62.3% reported for Q2 2022.
- Thailand targets 10 million foreign tourist arrivals this year, which should augur well for Bumrungrad.
Get started on the Smartkarma Research Network with a complimentary Preview Pass to:
- Unlock all research summaries
- Follow top, independent analysts
- Receive personalised alerts and emails
- Access Briefings, Analytics, and Events
Upgrade anytime to our paid plans for full-length research, real-time analyst discussions, and more.
Join a thriving community of 45,000+ investors, including the top global asset managers managing over $13trn in assets.
or
Already have an account? Sign In Now
Discussions
(Paid Plans Only)
Top Quartile
Tina Banerjee
Global Healthcare Analyst
Price Chart(Sign Up to Access)
- Bumrungrad Hospital (BH TB): Robust Performance Across All Segments Drove Q2 Result17 Aug 2023
- Bumrungrad Hospital (BH TB): International Business Is Roaring Back; Greenfield Project Approved09 Jul 2023
- Bumrungrad Hospital Pub Co (BH TB): Robust International Business Push Revenue Above Pre-COVID Level02 Dec 2022
- Bumrungrad Hospital Pub Co (BH TB): Flying High on Return of Medical Tourism28 Aug 2022
x